DIAZYME LABORATORIES, INC.
Patent Owner
Stats
- 31 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 01, 2018 most recent publication
Details
- 31 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 498 Total Citation Count
- Sep 01, 1999 Earliest Filing
- 19 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0138,960 DETECTION, MONITORING AND TREATMENT OF ACUTE MYOCARDIAL INFARCTIONFeb 02, 15May 18, 17[A61K, G01N]
2016/0334,404 VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFEAug 01, 16Nov 17, 16[C12N, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9000132 Lipoprotein-associated phospholipase A2 antibody compositions and methods of useJul 31, 13Apr 07, 15[C12N, G01N, C07K]
8673646 Electrochemical biosensor for direct determination of percentage of glycated hemoglobinMay 13, 09Mar 18, 14[G01N]
8460880 Compositions, splice variants and methods relating to ovarian specific genes and proteinsMar 24, 09Jun 11, 13[G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0353,986 METHODS FOR TREATMENT OF CORONARY HEART DISEASE EVENTS BASED ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITYAbandonedNov 13, 14Dec 10, 15[A61K, C12Q]
2015/0203,590 LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USEAbandonedApr 03, 15Jul 23, 15[G01N, C07K]
2015/0175,701 OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USEAbandonedDec 04, 14Jun 25, 15[A61K, G01N, C07K]
2015/0086,998 VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFEAbandonedMay 15, 14Mar 26, 15[C12Q, C12N, G01N]
2015/0086,999 LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2AbandonedMay 15, 14Mar 26, 15[G01N]
2014/0283,157 LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USEAbandonedMar 15, 13Sep 18, 14[C07K]
2013/0022,539 OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USEAbandonedJun 14, 12Jan 24, 13[A61K, C12N, G01N, A61P, C07K]
2011/0070,223 Uses of Lp-PLA2 in combination to assess coronary riskAbandonedNov 24, 10Mar 24, 11[A61K, C12Q, A61P]
7858325 Method of diagnosing, monitoring, staging, imaging and treating prostate cancerExpiredMar 06, 08Dec 28, 10[G01N]
2009/0269,345 CLN248 Antibody Compositions and Methods of UseAbandonedDec 22, 06Oct 29, 09[A61K, C12N, G01N, C07K]
7560531 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markersExpiredJun 01, 04Jul 14, 09[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.